吲哚胺-2,3-双加氧酶抑制剂联合铝佐剂对甲型肝炎减毒活疫苗诱导小鼠体液免疫应答的效应分析

doi:10.3969/j.issn.1674-5817.2017.02.005

实验动物与比较医学 ›› 2017, Vol. 37 ›› Issue (2): 108-112.DOI: 10.3969/j.issn.1674-5817.2017.02.005

吲哚胺-2,3-双加氧酶抑制剂联合铝佐剂对甲型肝炎减毒活疫苗诱导小鼠体液免疫应答的效应分析

何慧¹, 李彦涵¹, 李建芳¹, 马静², 胡云章¹, 胡凝珠¹

1.中国医学科学院北京协和医学院医学生物学研究所云南省虫媒传染病防控研究重点实验室, 昆明650118;
2.昆明医科大学, 昆明650500

收稿日期:2017-01-16 出版日期:2017-04-25 发布日期:2017-04-25
作者简介:何慧(1990-),女,硕士研究生,专业:生物化学与分子生物学,E-mail:1129368425@qq.com
基金资助:
国家科技支撑计划项目(2014BAI01B01);云南省创新团队“中国医学科学院医学生物学研究所新型疫苗佐剂应用研究省创新团队”(2011CI140);国家自然科学基金项目(31500748);国家重点研究计划生物安全关键技术研究发重点专项(2016YFC1202300)

Effects of Indoleamine-2,3-dioxygenase Inhibitor Combined with Aluminum Adjuvant on Humoral Immune Response Induced by Hepatitis A Virus Attenuated Live Vaccine in Mice

HE Hui¹, LI Yan-han¹, LI Jian-fang¹, MA Jing², HU Yun-zhang¹, HU Ning-zhu¹

1. Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Yunnan Key Laboratory of Prevention & Control Research on Insect-Borne Infectious Diseases,Kunming 650118, China;
2. Kunming Medical University, Kunming 650500, China

Received:2017-01-16 Online:2017-04-25 Published:2017-04-25

摘要/Abstract

摘要： 目的探讨吲哚胺-2,3-双加氧酶(IDO)抑制剂INCB024360类似物与铝佐剂联合对甲型肝炎减毒活疫苗(HepA-l)诱导小鼠体液免疫应答的影响,以评价其复合佐剂效应。方法分别将三种不同剂量的INCB024360类似物(150 μg, 100 μg, 50 μg)与Al(OH)₃(300 μg)复合后与HepA-1共同免疫ICR小鼠分别作为复合佐剂1组,2组,3组,同时设空白对照组、单纯疫苗组、铝佐剂对照组和单一INCB024360类似物(100 μg)组, 共免疫一次,于免疫后 4周、8周、12周、16周进行尾静脉采血, 采用间接酶联免疫吸附法(ELISA)检测小鼠血清抗甲型肝炎病毒(HAV) IgG 抗体水平。结果除空白对照组外, 各组小鼠免疫后4周、8周、12周、16周, 均产生抗HAV IgG抗体, 抗体水平随免疫时间的延长逐渐升高, 于12周达到峰值。复合佐剂2组[HepA-118 EU+Al(OH)₃300 μg+ INCB024360类似物100 μg]产生的抗体水平最高且持续时间较长, 在8周和12周时, 其对HepA-1的免疫增强效应显著高于单一佐剂组以及铝佐剂对照组(P<0.05, t值分别为3.169、2.439)。4周、8周、12周、16周, 单一佐剂组与单纯疫苗组差异均不具有统计学意义(P>0.05)。结论 IDO抑制剂INCB024360类似物与铝佐剂复合后具有较强的复合佐剂效应,免疫增强效应优于铝佐剂对照组; 但是单一的INCB024360类似物不具有显著佐剂效应。

关键词: 吲哚胺-2,3-双加氧酶(IDO), INCB024360类似物, 疫苗佐剂, 甲型肝炎减毒活疫苗(HepA-l), 体液免疫, 佐剂效应

Abstract: Objective To investigate the compound effect of indoleamine-2,3-dioxygenase (IDO)inhibitor INCB024360 analogue combined with aluminum adjuvant on humoral immune response induced by hepatitis A virus (HAV) attenuated live vaccine(HepA-l) in mice. Methods The ICR mice were injected respectively with HepA-l (18EU) and Al(OH)₃ (300 μg) and three different doses (150 μg, 100 μg, 50 μg) of INCB024360 analogue as experimental group, 200 μL for each and one immunization. At the same time, set up the blank group, pure vaccine group, aluminum adjuvant control group and single INCB024360 analogue (100 μg) group. The sera from tail vein blood of mice were collected at the end of 4, 8, 12 and 16 weeks after immunization and the specific IgG antibody against HAV were detected by indirect ELISA method. Results In addition to the blank group, mice in various group generated anti-HAV IgG at 4, 8, 12, 16 weeks after the immunization. The antibody levels increased as time went on and reached peak at 12 weeks, then decreased gradually. The antibody level of compound adjuvant 2 group is the highest. At 8, 12 weeks, the antibody level was significantly higher than pure vaccine group, aluminum adjuvant control group and single INCB024360 analogue group (P<0.05). At 4, 8, 12, 16 weeks, the difference between the single adjuvant group and the simple vaccine group was not statistically significant. Conclusions The compound adjuvant of IDO inhibitor INCB024360 analogue combined with aluminum adjuvant can obviously enhance the HepA-l induced humoral immune response in mice, and the immunity enhancement effect is better than aluminum adjuvant control group. But the single INCB024360 analogue does not have significant adjuvant effect.

Key words: Indoleamine-2,3-dioxygenase (IDO), INCB024360 analogue, Vaccine adjuvant, Hepatitis A virus attenuated live vaccine (HepA-l), Humoral immunity, Adjuvant effect

中图分类号:

Q95-33

何慧, 李彦涵, 李建芳, 马静, 胡云章, 胡凝珠. 吲哚胺-2,3-双加氧酶抑制剂联合铝佐剂对甲型肝炎减毒活疫苗诱导小鼠体液免疫应答的效应分析[J]. 实验动物与比较医学, 2017, 37(2): 108-112.

HE Hui, LI Yan-han, LI Jian-fang, MA Jing, HU Yun-zhang, HU Ning-zhu. Effects of Indoleamine-2,3-dioxygenase Inhibitor Combined with Aluminum Adjuvant on Humoral Immune Response Induced by Hepatitis A Virus Attenuated Live Vaccine in Mice[J]. Laboratory Animal and Comparative Medicine, 2017, 37(2): 108-112.

参考文献

[1] 张防正, 胡丽华. 吲哚胺-2,3-双加氧酶的免疫调节功能研究新进展[J]. 中国免疫学杂志, 2011, 27(1):93-95.
[2] Mellor A.Indoleamine-2,3-dioxygenase and regulation of T cell immunity[J]. Biochem Biophys Res Commun, 2005, 338(1):20-24.
[3] Pertovaara M, Hasan T, Raitala A, et al.Indoleamine-2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season[J]. Clin Exp Immunol, 2007, 150(2):274-278.
[4] Kahler DJ, Mellor AL.T cell regulatory plasmacytoid dendritic cells expressing indoleamine-2,3-dioxygenase[J]. Handb Exp Pharmacol, 2009, 188(188):167-196.
[5] Muller AJ, Duhadaway JB, Donover PS, et al.Inhibition of indoleamine-2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy[J]. Nat Med, 2005, 11(3):312-319.
[6] Peterson AC, La loggia AJ, Hamaker LK, et al.Evaluation of substituted β-carbolines as noncompetitive indoleamine-2,3-dioxygenase inhibitors[J]. Med Chem Res,1993, 25(35):473-482.
[7] 许思娟, 张连生, 吴重阳, 等. 抑制吲哚胺-2,3-双加氧酶活性促进慢性粒细胞白血病源树突状细胞的功能[J]. 中国肿瘤治疗杂志, 2009, 16(2):170-174.
[8] Munn DH.Expression of indoleamine-2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes[J]. J Clin Invest, 2004, 114(2):280-290.
[9] Okamoto A, Nikaido T, Ochiai K, et al.Indoleamine-2,3-dioxygenase serves as a maker of poor prognosis in gene expression profiles of serous ovarian cancer cells[J]. Clin Cancer Res, 2005, 11(16):6030-6039.
[10] Shi JG, Chen X, Punwani NG, et al.Potential under-prediction of Warfarin drug interaction from conventional interaction studies & risk mitigation: a case study with Epacadostat, an IDO1 Inhibitor[J]. J Clin Pharmacol, 2016, 56(11):1-11.
[11] Koblish HK, Hansbury MJ, Bowman KJ, et al.Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors[J]. Mol Cancer Ther, 2010, 9(2):489-498.
[12] Liu X, Shin N, Koblish HK, et al.Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity[J]. Blood, 2010, 115(17):3520-3530.
[13] 徐跃洋, 吴俊军. 吲哚胺-2, 3-双加氧酶IDO1抑制剂研究进展[J]. 中国新药杂志, 2016, 25(4):425-432.
[14] Hwu P, Du MX, Lapointe R, et al.Indoleamine-2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation[J]. J Immunol, 2000,164(7):3596-3599.
[15] 李赛凯, 徐静, 骆莹滨, 等. 吲哚胺-2,3-双加氧酶与肿瘤免疫逃逸关系的研究进展[J]. 癌症进展, 2016, 14(2):134-137.
[16] Schijns VE, Lavelle EC.Trends in vaccine adjuvants[J]. Expert Review Vaccines, 2011, 10(4):539-550.
[17] 吴超, 邹全明. 新型疫苗佐剂的研究进展[J]. 中国生物工程杂志, 2005, 25(8):10-15.
[18] Aguilar JC, Rodríguez EG.Vaccine adjuvants revisited[J]. Vaccine, 2007, 25(19):3752-3762.
[19] 王丽萍, 王越, 王海漩, 等. 酵母多糖-角鲨烯复合佐剂对甲型肝炎和乙型肝炎抗原诱导小鼠体液免疫应答的增强作用[J]. 中国生物制品学杂志, 2013, 26(4):473-476.
[20] 王琳, 王海漩, 李建芳, 等. 烟酰胺腺嘌呤二核苷酸与氢氧化铝联合佐剂对HBsAg诱导小鼠体液免疫应答的影响[J]. 中国生物制品学杂志, 2012, 25(9):1143-1146.
[21] Muller AJ, Duhadaway JB, Chang MY, et al.Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion[J]. Cancer Immunol Immunother,2010, 59(11):1655-1663.
[22] 楚松林, 李莉娟, 张连生, 等. 吲哚胺-2,3-双加氧酶:恶性肿瘤多维治疗模式下的新靶点[J]. 肿瘤, 2016, 36(6):711-717.

吲哚胺-2,3-双加氧酶抑制剂联合铝佐剂对甲型肝炎减毒活疫苗诱导小鼠体液免疫应答的效应分析

Effects of Indoleamine-2,3-dioxygenase Inhibitor Combined with Aluminum Adjuvant on Humoral Immune Response Induced by Hepatitis A Virus Attenuated Live Vaccine in Mice

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

本文评价

[1]	李晓红, 金晓, 贾森泉, 胡凝珠, 胡云章, 李建芳. 壬二酸佐剂对甲型肝炎减毒活疫苗诱导小鼠体液免疫应答效应分析[J]. 实验动物与比较医学, 2018, 38(2): 105-110.
[2]	贾森泉, 金晓, 李晓红, 王海璇, 胡凝珠, 胡云章. 硒化卡拉胶对甲型肝炎减毒活疫苗诱导的小鼠体液免疫应答的影响[J]. 实验动物与比较医学, 2018, 38(2): 111-116.
[3]	李彦涵, 李建芳, 孙静, 乌美妮, 王海璇, 胡云章. 应用树鼩对硫酸乙酰肝素佐剂的安全性初步评价[J]. 实验动物与比较医学, 2017, 37(5): 390-394.
[4]	马静, 王海漩, 李思瑾, 何慧, 胡凝珠, 胡云章. 4-苯基咪唑+氢氧化铝复合佐剂对甲型肝炎减毒活疫苗诱导小鼠体液免疫应答的影响[J]. 实验动物与比较医学, 2017, 37(2): 102-107.
[5]	王东宝, 胡云章, 胡凝珠, 罕园园, 匡德宣, 李彦涵. 树鼩经甲型肝炎减毒活疫苗、乙型肝炎疫苗及联合硫酸乙酰肝素佐剂免疫后的免疫效果评价[J]. 实验动物与比较医学, 2017, 37(2): 113-117.
[6]	高慧1, 2, 孙强2, 黄正芳2, 吴宝金1, 2, 李厚达2. 地方株HPV16L1基因诱发的小鼠体液免疫反应[J]. , 2005, 25(3): 143-146.